2026 Benjamin L. Ebert: Biology and Biochemistry Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	120	616	548	393	343	463	163818
Medicine	120	3648	3412	2015	1863	467	163919

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Biology and Biochemistry

120

616

548

393

343

463

163818

Medicine

120

3648

3412

2015

1863

467

163919

Biology and Biochemistry

D-Index

120

Citations

163818

World Ranking

616

National Ranking

393

Medicine

D-Index

120

Citations

163919

World Ranking

3648

National Ranking

2015

Overview

Benjamin L. Ebert is affiliated with Harvard University in the United States. Their research contributes extensively to the fields of medicine and biochemistry, genetics, and molecular biology, with a particular focus on hematology, molecular biology, genetics, immunology, and oncology.

The main topics addressed in their work include acute myeloid leukemia research, myeloproliferative neoplasms diagnosis and treatment, protein degradation and inhibitors, cancer genomics and diagnostics, ubiquitin and proteasome pathways, multiple myeloma research and treatments, and lymphoma diagnosis and treatment.

Some of Benjamin L. Ebert's recent publications comprise:

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN (2022, Blood)
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data (2022, Blood)
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes (2022, NEJM Evidence)
Cancer therapy shapes the fitness landscape of clonal hematopoiesis (2020, Nature Genetics)
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (2020, Nature Medicine)

Ebert's frequent collaborators include Pradeep Natarajan, Abhishek Niroula, Alexander G. Bick, Md Mesbah Uddin, and Christopher J. Gibson. These partnerships highlight an active engagement in cooperative research efforts.

Their publications are often found in notable scientific venues, such as:

Blood
bioRxiv (Cold Spring Harbor Laboratory)
Circulation
Blood Advances
Journal of Clinical Oncology

Best Publications

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Aravind Subramanian;Pablo Tamayo;Vamsi K. Mootha;Sayan Mukherjee

57054
Citations
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

Ophir Shalem;Ophir Shalem;Neville E Sanjana;Neville E Sanjana;Ella Hartenian;Xi-Shun Shi

12959
Citations
MicroRNA expression profiles classify human cancers

Jun Lu;Gad Getz;Eric A. Miska;Eric A. Miska;Ezequiel Alvarez-Saavedra

11815
Citations
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

5549
Citations
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal;Pierre Fontanillas;Jason Flannick;Jason Flannick;Alisa Manning

4411
Citations
The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei

4301
Citations
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Ross L. Levine;Ross L. Levine;Martha Wadleigh;Jan Cools;Benjamin L. Ebert;Benjamin L. Ebert

3760
Citations
Clonal Hematopoiesis and risk of atherosclerotic cardiovascular disease

Siddhartha Jaiswal;Pradeep Natarajan;Pradeep Natarajan;Alexander J. Silver;Christopher J. Gibson

2130
Citations
Clinical effect of point mutations in myelodysplastic syndromes.

Rafael Bejar;Kristen Stevenson;Omar Abdel-Wahab;Naomi Galili

1867
Citations
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

David P. Steensma;Rafael Bejar;Siddhartha Jaiswal;R. Coleman Lindsley

1865
Citations
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

Yana Pikman;Benjamin H Lee;Thomas Mercher;Elizabeth McDowell

1718
Citations
Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation

John G Doench;Ella Hartenian;Daniel B Graham;Zuzana Tothova

1689
Citations
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

Jan Krönke;Namrata D. Udeshi;Anupama Narla;Peter Grauman

1658
Citations
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia

Marc H. G. P. Raaijmakers;Siddhartha Mukherjee;Shangqin Guo;Siyi Zhang

1219
Citations
Stem cell gene expression programs influence clinical outcome in human leukemia

Kolja Eppert;Katsuto Takenaka;Eric R Lechman;Levi Waldron

1160
Citations
Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis

Noa Novershtern;Noa Novershtern;Noa Novershtern;Aravind Subramanian;Lee N. Lawton;Raymond H. Mak

1109
Citations
Identification of RPS14 as a 5q - syndrome gene by RNA interference screen

Benjamin L. Ebert;Jennifer Pretz;Jocelyn Bosco;Cindy Y. Chang

1081
Citations
Ribosomopathies: human disorders of ribosome dysfunction.

Anupama Narla;Benjamin L. Ebert;Benjamin L. Ebert

985
Citations
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

R. Coleman Lindsley;Brenton G. Mar;Emanuele Mazzola;Peter V. Grauman

963
Citations
Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis

Rafael Kramann;Rafael Kramann;Rebekka K. Schneider;Derek P. DiRocco;Flavia Machado

865
Citations